![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
S.a.l.a.r.s. S.p.a. Como It, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Morphine hydrochloride trihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2009-339 - Rev 01
This Chemical Type CEP, issued on June 20, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 97 associated with this CEP further emphasizes